Heron Springs Family Medicine Inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8425 Balm St, Weeki Wachee, FL 34607 Phone: 352-596-1770 Fax: 352-596-1553 |
Lindo Medical Care Llc Family Medicine Medicare: Medicare Enrolled Practice Location: 6463 Oregon Jay Rd, Weeki Wachee, FL 34613 Phone: 352-596-6114 Fax: 352-596-0784 |
Osteopathic Heritage, P.a. Family Medicine - Adult Medicine Medicare: Not Enrolled in Medicare Practice Location: 8246 River Country Dr, Weeki Wachee, FL 34607 Phone: 352-684-8637 Fax: 352-684-8638 |
Arecho Medical Clinic,llc Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 10045 Cortez Blvd, Ste. 122, Weeki Wachee, FL 34613 Phone: 352-596-0405 Fax: 352-597-4008 |
Center For Alternative Healing General Practice Medicare: Not Enrolled in Medicare Practice Location: 8405 Balm St, Weeki Wachee, FL 34607 Phone: 352-596-7887 |
St Peter Medical Clinic,inc Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 10045 Cortez Blvd, Suite # 110, Weeki Wachee, FL 34613 Phone: 352-592-2929 Fax: 352-592-2931 |
Total Health Network Llc Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 8403 Balm St, Weeki Wachee, FL 34607 Phone: 352-596-7887 Fax: 352-596-7886 |
Springs Family Physicians Llc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10200 Yale Ave, Weeki Wachee, FL 34613 Phone: 352-597-1960 Fax: 351-597-9470 |
Clemente P Nunag Md Pa Family Medicine Medicare: Medicare Enrolled Practice Location: 10222 Yale Ave, Weeki Wachee, FL 34613 Phone: 352-597-9797 Fax: 352-597-5556 |
News Archive
Academics and healthcare professionals from across Greater Manchester as well as people with a diagnosis of dementia and family carers have teamed up to devise a new training programme for general hospital staff.
Banyan Biomarkers, Inc. today announced that it has completed a $6 million series A funding from private investors for further biomarker research and continued development of a traumatic brain injury (TBI) diagnostic test. Currently, the company is enrolling subjects in a 2,000 patient pivotal clinical trial funded by a $26.3 million contract with the United States Department of Defense.
Results of a phase 3 trial published in The Lancet Oncology have confirmed that the drug abiraterone acetate (marketed as Zytiga®) offers a significant survival benefit to patients with castration-resistant prostate cancer, which is spreading to other parts of their body (known as metastatic prostate cancer).
In the past, the gold standard for the treatment of localized renal tumors has been radical nephrectomy. Over time however, experience with nephron sparing surgery and, now, laparoscopic approaches have demonstrated oncologic equipoise and may provide for an improved quality of life for patients as compared to those undergoing radical nephrectomy for localized renal masses.
› Verified 2 days ago